Literature DB >> 16175331

A Moloney murine leukemia virus driven by the Jaagsiekte sheep retrovirus enhancers shows enhanced specificity for infectivity in lung epithelial cells.

Kathleen McGee-Estrada1, Massimo Palmarini, Claus Hallwirth, Hung Fan.   

Abstract

Jaagsiekte sheep retrovirus (JSRV) is the etiologic agent of ovine pulmonary adenocarcinoma (OPA), a transmissible lung cancer in sheep. One of the unique features of this virus is that in infected animals, the only tissues that show expression of the virus are the tumor cells in the lung. We previously showed that the JSRV long terminal repeat (LTR) is preferentially active in murine lung epithelial cell lines (MLE-15 and mtCC1-2). To further explore the tissue specificity, we inserted the JSRV enhancer sequences from the U3 region of the LTR into a Moloney murine leukemia virus (M-MuLV) LTR lacking its own enhancer sequences, to give the chimeric LTR DeltaMo + JS. Transient transfection assays indicated that the DeltaMo + JS LTR is > 5-fold more active in lung epithelial cell lines than in non-lung lines, compared to the wild-type M-MuLV LTR. This was due to preferential activity of the JSRV enhancers in lung epithelial cells. Moreover, M-MuLV driven by the DeltaMo + JS LTR was > 3 logs more infectious in MLE-15 cells compared to non-lung cell lines. This chimeric virus may facilitate investigations of the tissue-specificity of JSRV.

Entities:  

Mesh:

Year:  2005        PMID: 16175331     DOI: 10.1007/s11262-005-3239-y

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  20 in total

1.  Retrovirus-induced ovine pulmonary adenocarcinoma, an animal model for lung cancer.

Authors:  M Palmarini; H Fan
Journal:  J Natl Cancer Inst       Date:  2001-11-07       Impact factor: 13.506

2.  Suppression of leukaemia virus pathogenicity by polyoma virus enhancers.

Authors:  B Davis; E Linney; H Fan
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

3.  Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.

Authors:  J Overhauser; H Fan
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

4.  Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.

Authors:  G Feuer; H Fan
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

5.  The long terminal repeat of Jaagsiekte sheep retrovirus is preferentially active in differentiated epithelial cells of the lungs.

Authors:  M Palmarini; S Datta; R Omid; C Murgia; H Fan
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

6.  Tumorigenic potential of a recombinant retrovirus containing sequences from Moloney murine leukemia virus and feline leukemia virus.

Authors:  C R Starkey; P A Lobelle-Rich; S W Granger; S Granger; B K Brightman; H Fan; L S Levy
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

7.  HNF-3beta is a critical factor for the expression of the Jaagsiekte sheep retrovirus long terminal repeat in type II pneumocytes but not in Clara cells.

Authors:  Kathleen McGee-Estrada; Massimo Palmarini; Hung Fan
Journal:  Virology       Date:  2002-01-05       Impact factor: 3.616

8.  Epithelial tumour cells in the lungs of sheep with pulmonary adenomatosis are major sites of replication for Jaagsiekte retrovirus.

Authors:  M Palmarini; P Dewar; M De las Heras; N F Inglis; R G Dalziel; J M Sharp
Journal:  J Gen Virol       Date:  1995-11       Impact factor: 3.891

9.  Production of immortalized distal respiratory epithelial cell lines from surfactant protein C/simian virus 40 large tumor antigen transgenic mice.

Authors:  K A Wikenheiser; D K Vorbroker; W R Rice; J C Clark; C J Bachurski; H K Oie; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

10.  Jaagsiekte sheep retrovirus is necessary and sufficient to induce a contagious lung cancer in sheep.

Authors:  M Palmarini; J M Sharp; M de las Heras; H Fan
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

View more
  7 in total

1.  Pantropic retroviruses as a transduction tool for sea urchin embryos.

Authors:  Amanda B Core; Arlene E Reyna; Evan A Conaway; Cynthia A Bradham
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

2.  In vivo and in vitro analysis of factor binding sites in Jaagsiekte sheep retrovirus long terminal repeat enhancer sequences: roles of HNF-3, NF-I, and C/EBP for activity in lung epithelial cells.

Authors:  Kathleen McGee-Estrada; Hung Fan
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

Review 3.  Coevolution of endogenous betaretroviruses of sheep and their host.

Authors:  F Arnaud; M Varela; T E Spencer; M Palmarini
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

4.  Specific in vivo expression in type II pneumocytes of the Jaagsiekte sheep retrovirus long terminal repeat in transgenic mice.

Authors:  Raffy M Dakessian; Hung Fan
Journal:  Virology       Date:  2007-12-03       Impact factor: 3.616

5.  Jaagsiekte sheep retrovirus biology and oncogenesis.

Authors:  Andrew Hofacre; Hung Fan
Journal:  Viruses       Date:  2010-12-03       Impact factor: 5.048

6.  Lung adenocarcinoma originates from retrovirus infection of proliferating type 2 pneumocytes during pulmonary post-natal development or tissue repair.

Authors:  Claudio Murgia; Marco Caporale; Ousman Ceesay; Gabriella Di Francesco; Nicola Ferri; Vincenzo Varasano; Marcelo de las Heras; Massimo Palmarini
Journal:  PLoS Pathog       Date:  2011-03-31       Impact factor: 6.823

7.  Use of Precision-Cut Lung Slices as an Ex Vivo Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy.

Authors:  María C Rosales Gerpe; Jacob P van Vloten; Lisa A Santry; Jondavid de Jong; Robert C Mould; Adrian Pelin; John C Bell; Byram W Bridle; Sarah K Wootton
Journal:  Mol Ther Methods Clin Dev       Date:  2018-08-04       Impact factor: 6.698

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.